Koers genOway SA Xetra
Aandelen
JEH
FR0004053510
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- EUR | - |
|
2023 | GenOway: sterke stijging, broker geeft koopaanbeveling | CF |
2023 | GENOWAY : Euroland opent buy-dekking | CF |
Omzet 2022 | 21,09 mln. 22,62 mln. | Omzet 2023 | 26,51 mln. 28,43 mln. | Marktkapitalisatie | 40,59 mln. 43,53 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | 1 mln. 1,07 mln. | EV/omzet 2022 | 1,87 x |
Nettoschuld 2022 | 4,16 mln. 4,46 mln. | Nettoschuld 2023 | 2,97 mln. 3,19 mln. | EV/omzet 2023 | 1,64 x |
K/w-verhouding 2022 * |
-
| K/w-verhouding 2023 |
-
| Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 72,58% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - | |
Founder | - | 01-03-99 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 01-10-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-03-99 | |
Raffy Kazandjian
BRD | Director/Board Member | - | - |
Patrick Blain
BRD | Director/Board Member | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,01% | 51,07 mld. | |
+34,80% | 38,61 mld. | |
-8,02% | 38,78 mld. | |
-8,98% | 27,32 mld. | |
+12,56% | 26,35 mld. | |
-19,62% | 19,46 mld. | |
+39,18% | 13,58 mld. | |
+31,47% | 12,46 mld. | |
-3,40% | 11,75 mld. |
- Beurs
- Aandelen
- Koers ALGEN
- Koers JEH